RxDoctor Payments Data

Terry Howard, DO

Family Medicine · Vonore, TNNPI 1003947128

Payments from drug & device makers

$370in general payments, 2019–2025

Across 13 payments — averaging $28.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Welch Allyn$92
  • Baxter Healthcare$86
  • Novo Nordisk$62
  • GSK$52
  • Abiomed$26
  • Nevro Corp.$20
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$19352%
  • Other$17748%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$370 in reported general payments places this provider in the 45th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$11,045
Medicare patients
115
Services billed
973

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide316$364,601
JardianceEmpagliflozin123$134,774
EliquisApixaban73$92,086
TrulicityDulaglutide58$56,256
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$49,882
JanuviaSitagliptin Phosphate50$45,049
FarxigaDapagliflozin Propanediol38$30,565
XareltoRivaroxaban28$29,373
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$26,198
Breo ElliptaFluticasone/Vilanterol32$16,688
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$14,679
Spiriva RespimatTiotropium Bromide19$10,233
Tresiba Flextouch U-100Insulin Degludec18$10,146
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$8,959
Novolog FlexpenInsulin Aspart33$6,919

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Levemir$62$369,489330 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$52$81,249104 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Vonore

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →